MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC13; ANTI-REFLUX IMPLANT

Model Number LXC-[13]

Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Diarrhea (1811); Dysphagia/ Odynophagia (1815); Pyrosis/Heartburn (1883); Pain (1994); Vomiting (2144); Abdominal Distention (2601); Pericarditis (4448); Cramp(s) /Muscle Spasm(s) (4521)

Event Date 05/10/2022

Event Type  Injury  

Event Description

It was reported via clinical trial patient (b)(6): experience, esophageal spasms.  the event was not related to the study device. .

Manufacturer Narrative

(b)(4).Date of event: unknown; captured as awareness date.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received; device size: 13, linx device model: suture, lot number: 3994, serial number: (b)(4), relationship to the device/procedure: yes/probably/possibly is there a reasonable possibility that the event is associated with the device or the procedure: yes healthcare utilization: medication.Patients dob (b)(6) 1968, female.Height 62 inches weight (b)(6) lbs bmi 26.52 6 month follow up: do you have difficulty swallowing? answer was a 1 so yes.Do you have bloat or gassy feelings answer was 2 so yes.Diarrhea.36 month follow up: heartburn level 2 / 4/ 3 so yes.Medication taken for gerd¿s level 2 so yes.Severe heart burn.Severe chest pain.60month follow up.Heartburn level 1.Bloaty or gassy feelings level 1 chest pain.72 month follow: bloaty or gassy feelings level 2 pain bloating increased gas.84 month follow up heart burn, difficulty swallowing, bloaty or gassy feeling, pain.Heartburn chest pain difficulty swallowing pain with swallowing.Er visit.Date of admission (b)(6) 2015.Pt.Experiencing multiple episodes of severe chest pain that radiate up into her right jaw.First episode was (b)(6) 2015 that resolved spontaneously with emesis.She was seen in the er on (b)(6) 2015 for chest pain and again on (b)(6) 2015.Extensive workup at both the emergency room were negative.Follow-up included a negative upper gi and esophagram on (b)(6) 2015.Cardiology workup on (b)(6) 2015 suggested pericarditis.Pt.Had another episode of pain resulting in an extended er visit on (b)(6) 2015 again without evidence of any abnormalities including normal cbc, cmp, cardiac enzymes, chest x-ray, ekg, cta, vq scan.Patient did not respond to nitroglycerin but had some relief with one dose 73 date generated: (b)(6) 2015 19:42:22 (utc) of baclofen.Pi believes she is having esophageal spasms.Pt.Prescribed dietary modifications, baclofen, and repeat dose of medrol dosepak to decrease any surrounding inflammation as well as address the esophageal spasms.After medrol dosepak, modification ,and baclofen patient¿s symptoms had significantly improved in late march.Pt had a few more episodes in april but have completely resolved as of today.Detailed description of the deviation and rationale 6 month follow up performed outside of expected visit window.Schedule visits earlier.Subject had multiple medical issues and needed to be on gerd medication.Subject unwilling or unable to tolerate procedure or evaluation.Unable to contact pt.Subject did not sign informed consent prior to procedure/inadequate consent process.Previous coordinator did not provide consent addendum to patient.Study assigned to coordinator during subject 72m follow[1]up outside window per.Site oversight; inappropriate calculation of visit window.Corrected patient specific calendar for future visits, based on implant date.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.

Manufacturer Narrative

(b)(4).Date sent: 6/13/2022.Investigation summary an analysis of the product could not be performed since a physical sample was not received for evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.A manufacturing record evaluation was performed for the finished device lot number 3994, and no non-conformances were identified.However, if the product is received at a later date, the investigation will be updated as applicable.

• Brand Name: LXC13
• Type of Device: ANTI-REFLUX IMPLANT
• Manufacturer (Section D): TORAX MEDICAL, INC.; 4188 lexington avenue north; shoreview MN
• Manufacturer Contact: orla o'mahony ; 4188 lexington avenue north; shoreview 55126
• MDR Report Key: 14549950
• MDR Text Key: 292994057
• Report Number: 3008766073-2022-00109
• Device Sequence Number: 1
• Product Code: LEI
• UDI-Device Identifier: 00855106005141
• UDI-Public: 00855106005141
• Combination Product (y/n): N
• PMA/PMN Number: P100049
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Study
• Reporter Occupation: Other
• Type of Report: Initial,Followup
• Report Date: 06/13/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Expiration Date: 09/27/2016
• Device Model Number: LXC-[13]
• Device Catalogue Number: LXC13
• Device Lot Number: 3994
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Initial Date Manufacturer Received: 05/10/2022
• Initial Date FDA Received: 05/31/2022
• Supplement Dates Manufacturer Received: 06/13/2022
• Supplement Dates FDA Received: 06/13/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 09/27/2012
• Is the Device Single Use?: Yes
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Hospitalization; Required Intervention
• Patient Age: 54 YR
• Patient Weight: 66 KG